APA

Lim H. I., Yamamoto J., Inubushi S., Nishino H., Tashiro Y., Sugisawa N., Han Q., Sun Y. U., Choi H. J., Nam S. J., Kim M. B., Lee J. S., Hozumi C., Bouvet M., Singh S. R. & Hoffman R. M. (20200518). A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model. : Anticancer research.

Chicago

Lim Hye In, Yamamoto Jun, Inubushi Sachiko, Nishino Hiroto, Tashiro Yoshihiko, Sugisawa Norihiko, Han Quinhong, Sun Y U, Choi Hee Jun, Nam Seok Jin, Kim Moon Bo, Lee Ji Sun, Hozumi Chihiro, Bouvet Michael, Singh Shree Ram and Hoffman Robert M. 20200518. A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model. : Anticancer research.

Harvard

Lim H. I., Yamamoto J., Inubushi S., Nishino H., Tashiro Y., Sugisawa N., Han Q., Sun Y. U., Choi H. J., Nam S. J., Kim M. B., Lee J. S., Hozumi C., Bouvet M., Singh S. R. and Hoffman R. M. (20200518). A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model. : Anticancer research.

MLA

Lim Hye In, Yamamoto Jun, Inubushi Sachiko, Nishino Hiroto, Tashiro Yoshihiko, Sugisawa Norihiko, Han Quinhong, Sun Y U, Choi Hee Jun, Nam Seok Jin, Kim Moon Bo, Lee Ji Sun, Hozumi Chihiro, Bouvet Michael, Singh Shree Ram and Hoffman Robert M. A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model. : Anticancer research. 20200518.